Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
Public ClinicalTrials.gov record NCT00745316. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency
Study identification
- NCT ID
- NCT00745316
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Biogen
- Industry
- Enrollment
- 34 participants
Conditions and interventions
Conditions
Interventions
- Tonapofylline Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2009
- Primary completion
- Dec 31, 2009
- Completion
- Dec 31, 2009
- Last update posted
- Sep 10, 2023
2009 – 2010
United States locations
- U.S. sites
- 30
- U.S. states
- 21
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Huntsville | Alabama | 35801 | — |
| Not listed | Mobile | Alabama | 36608 | — |
| Not listed | Scottsdale | Arizona | 85251 | — |
| Not listed | Tucson | Arizona | 85710 | — |
| Not listed | Beverly Hills | California | 90210 | — |
| Not listed | San Diego | California | 92103 | — |
| Not listed | Denver | Colorado | 80218 | — |
| Not listed | Bridgeport | Connecticut | 06606 | — |
| Not listed | Jacksonville | Florida | 32209 | — |
| Not listed | Melbourne | Florida | 32901 | — |
| Not listed | Ormond Beach | Florida | 32174 | — |
| Not listed | Chicago | Illinois | 60612 | — |
| Not listed | Maywood | Illinois | 60153 | — |
| Not listed | Indianapolis | Indiana | 46260 | — |
| Not listed | Iowa City | Iowa | 52242 | — |
| Not listed | Owensboro | Kentucky | 42303 | — |
| Not listed | Baltimore | Maryland | 21201 | — |
| Not listed | Boston | Massachusetts | 02114 | — |
| Not listed | Boston | Massachusetts | 02115 | — |
| Not listed | Minneapolis | Minnesota | 55415 | — |
| Not listed | Lincoln | Nebraska | 68506 | — |
| Not listed | The Bronx | New York | 10461 | — |
| Not listed | Cincinnati | Ohio | 45219 | — |
| Not listed | Cincinnati | Ohio | 45267 | — |
| Not listed | Oklahoma City | Oklahoma | 73120 | — |
| Not listed | Lancaster | Pennsylvania | 17602 | — |
| Not listed | Germantown | Tennessee | 38138 | — |
| Not listed | Roanoke | Virginia | 24014 | — |
| Not listed | Beloit | Wisconsin | 53511 | — |
| Not listed | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00745316, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 10, 2023 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00745316 live on ClinicalTrials.gov.